KTMS expands dialysis network; licensing delays shift revenue timing
Strong core dialysis growth and expansion KTMS's core hemodialysis revenue rose 9.34% in H1 2026 on more patients and new branches. It plans to add 3-5 units and 36-64 machines in H2, targeting 800 million baht revenue for 2026. This growth supports a higher share price.
It shows the main business is growing and expanding, directly driving future revenue and profit.
High demand for dialysis services Thailand has about 8 million people at risk of kidney disease and 120,000 needing dialysis, with 80% choosing hemodialysis. KTMS's new branches already run at over 80% utilisation, showing strong demand that can lift future earnings.
It explains the underlying demand that supports KTMS's expansion and revenue targets.
Licensing delays push back revenue Government licensing for new dialysis branches now takes about 120 days, up from 90 days. This delays when new branches can start earning money, so some revenue expected earlier may come later. It's a timing issue, not a loss of revenue.
It is a real counterweight that could slow near-term revenue recognition and pressure the stock.
Q4 2026 outlook improves as branches open KTMS expects better Q4 2026 results as new branches gradually open and utilisation stays at least 80%. This suggests revenue will accelerate once licensing clears, supporting the stock.
It gives a forward-looking positive catalyst that could drive the stock higher.